false
OasisLMS
Login
Catalog
AACE MENA 2025
Endocrine Practice in Resource Limited Settings
Endocrine Practice in Resource Limited Settings
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The speaker discusses challenges and opportunities for endocrinology practice in resource-limited settings, emphasizing that “resource limitation” is not only about cost, but also access and quality. Drawing on experience in Pakistan and multiple US practice environments, they show how insurance design, clinic policies (e.g., not accepting Medicaid), and profit-driven systems can restrict access even in high-income countries, while some medications may be cheaper and more obtainable in lower-income settings.<br /><br />Using a type 2 diabetes case, they contrast guideline-preferred therapies (SGLT2 inhibitors/GLP-1s) with what patients can actually obtain, highlighting dramatic price differences between Pakistan and the US. A thyroid cancer case illustrates another limitation: inability to afford thyrogen leading to levothyroxine withdrawal before radioactive iodine, compromising quality of life though outcomes can still be good.<br /><br />Universal challenges include medication shortages, lack of specialists, and uneven geographic access. Opportunities include advocacy and legislation (e.g., insulin access initiatives), adapting international guidelines to local realities (“adolopment”), and leveraging telehealth, CGM data-sharing, low-tech tools, and AI to identify risk, improve communication, detect bias, and expand trial diversity. The talk concludes that equity requires combining evidence with practical implementation, aided by advocacy and technology.
Meta Tag
Concept
Resource Limitation
Concept
Inequity
Concept
Access
Concept
Endocrine Practice
Concept
Diabetes
Keywords
endocrinology resource-limited settings
healthcare access and equity
type 2 diabetes medication affordability
SGLT2 inhibitors and GLP-1 receptor agonists
thyroid cancer radioactive iodine preparation
guideline adolopment (adaptation)
telehealth CGM and AI in endocrinology
Resource Limitation
Inequity
Access
Endocrine Practice
Diabetes
×
Please select your language
1
English